The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health ...
Additionally, Merck’s Animal Health unit acquired Elanco’s aqua business. Merck also launched WINREVAIR, a new vaccine for ...
Merck's consistent dividend payments over 34 years, healthy balance sheet, and attractive valuation highlight its investment ...
Zacks.com on MSN20d
Merck to Report Q3 Earnings: To Buy or Not to Buy MRK Stock?Merck’s Animal health and vaccine products are core growth drivers. It has a strong cancer pipeline, including Keytruda.
Zacks.com on MSN24d
Merck Stock Down More Than 14% in 6 Months: Buy, Sell or Hold?Merck’s Animal health and vaccine products are core growth drivers. It has a strong cancer pipeline, including Keytruda.
The Human Health segment saw 11% growth, Animal Health grew by 6%, and KEYTRUDA sales surged by 21%. Vaccines like GARDASIL ...
Hosted on MSN10d
Merck & Co. Stock: Is Wall Street Bullish or Bearish?With a market cap of $258 billion, Merck & Co., Inc. (MRK) is a global healthcare company, operating in the pharmaceutical and animal health sectors. Based in Rahway, New Jersey, Merck develops ...
The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business. But Merck's vaccine that prevents cancer from HPV ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback